Physicians Formula (FACE) Issues FY12 Outlook
Physicians Formula (Nasdaq: FACE) sees FY12 EPS of 7-15 cents on sales which are expected to be up 7-10 percent. The Street is currently expecting FY12 EPS of 16 cents.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BGC Partners (BGCP) Reports In-Line Q2 EPS
- American Tower (AMT) Reports Q2 FFO of $1.33
- Triumph Group (TGI) Sinks 18% Following Mixed Q1 Results
Create E-mail Alert Related CategoriesGuidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!